Desmopressin oral solution now available

Consilient Health has launched an oral solution containing desmopressin 360 microgram per ml for the treatment of cranial diabetes insipidus and primary nocturnal enuresis. Previously, desmopressin oral solution or suspension was available only on a special order basis.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

NSAIDs safe in COVID-19, study confirms

NSAIDs safe in COVID-19, study confirms

Concerns were raised early in the COVID-19 pandemic...

Deleted products - live tracker

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

New and deleted indications - live tracker

New and deleted indications - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest changes to...